消息
×
loading..
中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • 王皞鹏

    合作成果数：8

  • 范高峰

    合作成果数：7

  • 王月桐

    合作成果数：5

  • 邱士真

    合作成果数：2

  • 尚婉婧

    合作成果数：2

访问统计


  总访问量
 638
  访问来源
    内部： 5
    外部： 633
    国内： 472
    国外： 166

  年访问量
 88
  访问来源
    内部： 0
    外部： 88
    国内： 84
    国外： 4

  月访问量
 6
  访问来源
    内部： 0
    外部： 6
    国内： 6
    国外： 0

访问量

访问量

1. Chimeric Antigen Receptor Designed to Prevent Ubiquitination and D.. [572]
2. Key elements for designing and performing a CRISPR/Cas9-based gene.. [539]
3. NAD(+) supplement potentiates tumor-killing function by rescuing d.. [516]
4. NAD+和//或NAD+抑制剂和//或NAD+激动剂的用途及其联合制剂 [325]
5. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [301]
6. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [281]
7. CRISPR/Cas9-Based Genetic Screening to Study T-Cell Function [271]
8. Use of NAD+ and//or NAD+ inhibitors and // or NAD+ agonists and co.. [250]
9. Therapeutic targeting nudix hydrolase 1 creates a MYC-driven metab.. [156]

下载量

1. Chimeric Antigen Receptor Designed to Prevent Ubiquitination and D.. [27]
2. Key elements for designing and performing a CRISPR/Cas9-based gene.. [5]
3. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [1]
4. Therapeutic targeting nudix hydrolase 1 creates a MYC-driven metab.. [1]